International Journal of Health Policy and Management

1. Progressive Realisation of Universal Health Coverage in Low- and Middle-Income Countries: Beyond the “Best Buys”

Articles in Press, Corrected Proof, Available Online from 17 February 2021

10.34172/ijhpm.2020.245

Melanie Y. Bertram; Jeremy A. Lauer; Karin Stenberg; Ambinintsoa H. Ralaidovy; Tessa Tan-Torres Edejer

2. Cost-Effectiveness of Interventions to Improve Maternal, Newborn and Child Health Outcomes: A WHO-CHOICE Analysis for Eastern Sub-Saharan Africa and South-East Asia

Articles in Press, Corrected Proof, Available Online from 17 March 2021

10.34172/ijhpm.2021.07

Karin Stenberg; Rory Watts; Melanie Y. Bertram; Kaia Engesveen; Blerta Maliqi; Lale Say; Raymond Hutubessy

3. HTA Agencies Need Evidence-Informed Deliberative Processes; Comment on “Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe”

Volume 10, Issue 3, March 2021, Pages 158-161

10.34172/ijhpm.2020.22

Michael Schlander

4. Expanding the Role of Early Health Economic Modelling in Evaluation of Health Technologies; Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling”

Volume 10, Issue 2, February 2021, Pages 102-105

10.15171/ijhpm.2020.18

Carlo Federici; Aleksandra Torbica

5. Characterizing the Validity and Real-World Utility of Health Technology Assessments in Healthcare: Future Directions; Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modelling”

Volume 9, Issue 8, August 2020, Pages 352-355

10.15171/ijhpm.2019.132

Nadine K. Zawadzki; Joel W. Hay

6. Transforming Disciplinary Traditions; Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling”

Volume 9, Issue 7, July 2020, Pages 309-311

10.15171/ijhpm.2019.130

Pascale Lehoux; Hudson Silva

7. Use of Evidence-Informed Deliberative Processes – Learning by Doing; Comment on “Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe”

Volume 9, Issue 6, June 2020, Pages 263-265

10.15171/ijhpm.2019.116

Anthony J. Culyer

8. Cost-Effectiveness Analysis of Psoriasis Treatment Modalities in Malaysia

Volume 8, Issue 7, July 2019, Pages 394-402

10.15171/ijhpm.2019.17

Nor Azmaniza Azizam; Aniza Ismail; Saperi Sulong; Norazirah Md Nor

9. Reflections on Norheim (2018), Disease Control Priorities Third Edition Is Published; Comment on “Disease Control Priorities Third Edition Is Published: A Theory of Change Is Needed for Translating Evidence to Health Policy”

Volume 8, Issue 6, June 2019, Pages 375-377

10.15171/ijhpm.2019.09

Rachel Nugent

10. Healthcare Priority-Setting: Chat-Ting Is Not Enough; Comment on “Swiss-CHAT: Citizens Discuss Priorities for Swiss Health Insurance Coverage”

Volume 7, Issue 10, October 2018, Pages 961-963

10.15171/ijhpm.2018.66

Leonard M. Fleck

11. Don’t Discount Societal Value in Cost-Effectiveness; Comment on “Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness”

Volume 6, Issue 9, September 2017, Pages 543-545

10.15171/ijhpm.2017.03

William Hall

12. Diplomacy and Health: The End of the Utilitarian Era

Volume 6, Issue 4, April 2017, Pages 191-194

10.15171/ijhpm.2016.155

Sebastian Kevany; Marcus Matthews

13. Expanded HTA: Enhancing Fairness and Legitimacy

Volume 5, Issue 1, January 2016, Pages 1-3

10.15171/ijhpm.2015.187

Norman Daniels; Thalia Porteny; Julian Urritia

14. Including Both Costs and Effects – The Challenge of Using Cost-Effectiveness Data in National-Level Policy-Making: A Response to Recent Commentaries

Volume 4, Issue 8, August 2015, Pages 565-566

10.15171/ijhpm.2015.123

Nathalie Eckard; Magnus Janzon; Lars-Åke Levin

15. The Use (or rather the non-Use) of Cost-Effectiveness Data in Priority Setting Decisions – Are We Underestimating the Barriers to Using Health Economics in Real World Priority Setting Decisions?; Comment on “Use of Cost-Effectiveness Data in Priority Setting Decisions: Experiences from the National Guidelines for Heart Diseases in Sweden”

Volume 4, Issue 3, March 2015, Pages 181-183

10.15171/ijhpm.2015.28

Sandra Erntoft

16. Use of Cost-Effectiveness Data in Priority Setting Decisions: Experiences from the National Guidelines for Heart Diseases in Sweden

Volume 3, Issue 6, November 2014, Pages 323-332

10.15171/ijhpm.2014.105

Nathalie Eckard; Magnus Janzon; Lars-Åke Levin

17. The Financial Cost of Preventive and Curative Programs for Breast Cancer: A Case Study of Women in Shiraz-Iran

Volume 2, Issue 4, May 2014, Pages 187-191

10.15171/ijhpm.2014.44

Nahid Hatam; Vahid Keshtkar; Asiyeh Salehi; Hamidreza Rafei

International Journal of Health Policy and Management

Journal Archive

Volume 10 (2021)

Volume 9 (2020)

Volume 8 (2019)

Volume 7 (2018)

Volume 6 (2017)

Volume 5 (2016)

Volume 4 (2015)

Volume 3 (2014)

Volume 2 (2014)

Volume 1 (2013)